Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The record history shows a new revision label, Revision: v3.5.4, replacing the previous v3.5.3. This reflects a metadata update to the page’s revision history rather than changes to the study content or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:19:12.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor update to the ClinicalTrials.gov interface/version rather than a study data change.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:25.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the history. The change appears to be a system or UI update rather than content changes to the study records.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:46.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    - Added revision v3.5.0 to the Study Record Versions. - Removed revision v3.4.3 from history.
    Difference
    0.1%
    Check dated 2026-03-18T21:19:52.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 in the page footer. This is a minor system update and does not alter study records or user workflows.
    Difference
    0.1%
    Check dated 2026-03-11T18:33:31.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The page adds Revision: v3.4.2 and removes the government funding lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.5%
    Check dated 2026-02-11T06:37:13.000Z thumbnail image

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.